Saloni Tanna

Saloni Tanna

Hematology | Oncology

1255 Friendship Road
Suite 230
Braselton, GA 30517

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).

A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).

Journal: Clinical lung cancer

Published: July 13, 2020

Showing 1-1 of 1

Last Updated: 09/26/2026